Navigation Links
Queensland Bans OTC Sales Of Cold And Flu Drugs

Health Minister Stephen Robertson announced that cold and flu drugs containing pseudoephedrine will be banned from being sold over the counter in an effort to limit illegal manufacturing of such drugs. //

This new rule is set to come into effect from January 1 in Queensland. Pharmacists have been asked to ensure that unknown and frequent buyers are thoroughly questioned in order to find out if their need is genuine. Pseudoephedrine is often used as a raw material to manufacture speed and combination with cocaine. This is the most abused drug on the streets among the youth.

It has also emerged that the Pharmacy Guild of Australia will monitor the sales of these cold and flu drugs so that amphetamine labs do not crop up all over the state. "We believe that more stringent point of sale control on these medicines is necessary to help combat the manufacture of illicit drugs in Queensland," Mr Robertson said. “The continued diversion of medicines containing pseudoephedrine for use as a precursor to manufacture methamphetamine is an issue of grave concern for health regulators and law enforcement agencies." Under the rule nasal decongestants and cold and flu medications would be under scrutiny because other medications used for cold and flu do not contain pseudoephedrine. Robertson admitted that genuine patients would feel hassled by this new rule, but said it was needed to ensure that illegal practices did not flower in the state.


'"/>




Page: 1

Related medicine news :

1. Queensland Opposition not happy over hiring consultancy
2. The mystery of the bulge in North Queenslanders
3. Queensland : Call for improved mental health services
4. Mammograms in Queensland Reviewed
5. Queensland Government to Meet its Medical Targets
6. Meningococcal Scare in Queensland
7. Medical Person As Health Minister To Improve Queenslands Health System
8. Dentist Tested Positive For HIV - Queensland Health To Screen Patients
9. Queensland Health Holding Back Dental Patients HIV Results
10. Queensland Staff Shortage Crisis Escalates
11. Unnecessary Diseases on the Rise in Queensland (Australia)
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
(Date:10/12/2017)... Bethesda, MD (PRWEB) , ... October 12, 2017 , ... ... Award of Excellence to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s ... 4 – 8. , In honor of Morris F. Collen, a pioneer in the ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)...  Eli Lilly and Company (NYSE: LLY ... quarter of 2017 on Tuesday, October 24, 2017. Lilly ... with the investment community and media to further detail ... will begin at 9 a.m. Eastern time. Investors, media ... of the conference call through a link that will ...
(Date:9/28/2017)... 2017 Cohen Veterans Bioscience and Early Signal ... wearable and home sensors for real-time monitoring of patients ... a nonprofit organization focused on disruptive health solutions for ... analytical system to record and integrate behavioral, cognitive, physiological ... ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
Breaking Medicine Technology: